Cargando…

Liraglutide Improves Hypertension and Metabolic Perturbation in a Rat Model of Polycystic Ovarian Syndrome

Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive age, with a prevalence of 5–8%. Type 2 diabetes and cardiovascular disease (CVD) are its long-term complications. Targeted therapies addressing both these complications together are lacking. Glucagon li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoang, Vanessa, Bi, Jiangjiang, Mohankumar, Sheba M., Vyas, Arpita K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444207/ https://www.ncbi.nlm.nih.gov/pubmed/26010091 http://dx.doi.org/10.1371/journal.pone.0126119

Ejemplares similares

MON-028 Chronic Resveratrol Exposure Improves Glucose Homeostasis and Cardiac Function in a Rat Model of Polycystic Ovarian Syndrome
por: Molina, Rogelio Enrique, et al.
Publicado: (2020)

Liraglutide and polycystic ovary syndrome: is it only a matter of body weight?
por: Pugliese, G., et al.
Publicado: (2023)

Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome
por: Xing, Chuan, et al.
Publicado: (2022)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

Dysregulated Liver Metabolism and Polycystic Ovarian Syndrome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2023)

Metabolic syndrome in infertile women with polycystic ovarian syndrome
por: Madani, Tahereh, et al.
Publicado: (2016)

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
por: JENSTERLE, MOJCA, et al.
Publicado: (2016)

Liraglutide in polycystic ovary syndrome: a randomized trial, investigating effects on thrombogenic potential
por: Nylander, Malin, et al.
Publicado: (2017)

Alterations of polyunsaturated fatty acid metabolism in ovarian tissues of polycystic ovary syndrome rats
por: Huang, Rong, et al.
Publicado: (2018)

Neuroendocrine effects of perfluorooctane sulfonate in rats.
por: Austin, Maureen E, et al.
Publicado: (2003)

The Prevalence of Metabolic Syndrome in the Different Phenotypes of Polycystic Ovarian Syndrome
por: Tavares, Aleide, et al.
Publicado: (2019)

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls
por: Kahal, Hassan, et al.
Publicado: (2015)

High-dose liraglutide improves metabolic syndrome in poor responders to bariatric surgery
por: Vinciguerra, Federica, et al.
Publicado: (2023)

SAT-719 Prenatal Exposure to Bisphenol A, S and F Increases Blood Pressure in Female Rats
por: Al Mansi, Maryam H, et al.
Publicado: (2020)

Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women
por: Dadachanji, Roshan, et al.
Publicado: (2021)

Effects of Aerobic Exercise on Rats with Hyperandrogenic Polycystic Ovarian Syndrome
por: Li, Na, et al.
Publicado: (2021)

Correlation of Vitamin D with metabolic parameters in polycystic ovarian syndrome
por: Kumar, Arun, et al.
Publicado: (2017)

Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats
por: Trang, Nguyen Ngoc, et al.
Publicado: (2021)

Protective effects of GABA against metabolic and reproductive disturbances in letrozole induced polycystic ovarian syndrome in rats
por: Ullah, Asad, et al.
Publicado: (2017)

Liraglutide administration improves hormonal/metabolic profile and reproductive features in women with HAIR-AN syndrome
por: Livadas, S, et al.
Publicado: (2020)

SAT065 Developmental Programming: Sex-specific Programming Of Pancreas In A Sheep Model Of Polycystic Ovary Syndrome
por: Halloran, Katherine M, et al.
Publicado: (2023)

Ovarian Metabolic activity in Dehydroepiandrosterone-Induced Polycystic Ovary in Wistar rats Treated with Aspirin
por: Olaniyan, Olugbemi T, et al.
Publicado: (2020)

The Source of Polycystic Ovarian Syndrome
por: Raperport, Claudia, et al.
Publicado: (2019)

Polycystic Ovarian Syndrome in Adolescents
por: Adone, Avanti, et al.
Publicado: (2023)

The Effect of Green Tea Extract on Reproductive Improvement in Estradiol Valerate-Induced Polycystic Ovarian Syndrome in Rat
por: Ghafurniyan, Habibeh, et al.
Publicado: (2015)

The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
por: Yang, Hyun, et al.
Publicado: (2022)

Metabolic Concomitants of Obese and Nonobese Women With Features of Polycystic Ovarian Syndrome
por: Boumosleh, Jocelyne Matar, et al.
Publicado: (2017)

Male Equivalent Polycystic Ovarian Syndrome: Hormonal, Metabolic and Clinical Aspects
por: Di Guardo, Federica, et al.
Publicado: (2020)

SAT-717 Region-Specific Effects of the Exposome on Brain Monoamine Levels in Female Rats
por: Kaimal, Amrita, et al.
Publicado: (2020)

Prevalence of metabolic syndrome in polycystic ovarian syndrome women in a hospital of Tehran
por: Moini, Ashraf, et al.
Publicado: (2012)

Phyllanthus muellerianus (Euphorbiaceae) Restores Ovarian Functions in Letrozole-Induced Polycystic Ovarian Syndrome in Rats
por: Ndeingang, Eveline Christiane, et al.
Publicado: (2019)

Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure
por: Chen, Jiying, et al.
Publicado: (2021)

Metformin effectively restores the HPA axis function in diet-induced obese rats
por: Shin, Andrew C., et al.
Publicado: (2020)

Metformin improves polycystic ovary syndrome in mice by inhibiting ovarian ferroptosis
por: Peng, Qingjie, et al.
Publicado: (2023)

Effect of green tea on metabolic and hormonal aspect of polycystic ovarian syndrome in overweight and obese women suffering from polycystic ovarian syndrome: A clinical trial
por: Tehrani, Hatav Gasemi, et al.
Publicado: (2017)

Hochu-ekki-to Treatment Improves Reproductive and Immune Modulation in the Stress-Induced Rat Model of Polycystic Ovarian Syndrome
por: Park, Eunkuk, et al.
Publicado: (2017)

In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation
por: Venegas, Berenice, et al.
Publicado: (2019)

Evaluation of the Central Effects of Systemic Lentiviral-Mediated Leptin Delivery in Streptozotocin-Induced Diabetic Rats
por: Clark, Kimberly A., et al.
Publicado: (2021)

Neuroprotective Effects of Liraglutide for Stroke Model of Rats
por: Sato, Kenichiro, et al.
Publicado: (2013)

Cardiometabolic aspects of polycystic ovarian syndrome
por: Cho, Li Wei, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_e1c0l05jcdroe1o73tu6k98qde